It was March 2020, and the COVID-19 pandemic was just starting to rage at hospitals across the country and at The Ohio State University Wexner Medical Center.
"We became very concerned because we knew that these patients with COVID-19, they were incredibly ill," said Eileen Faulds, assistant professor at the OSU College of Nursing and endocrinology nurse practitioner at the OSU Wexner Medical Center. "We knew that if you had a diagnosis of diabetes you were more likely to develop critical illness if you did get COVID-19. And then, when you are critically ill, having good blood glucose control is incredibly important, so we knew these patients needed IV insulin, so they needed a continuous infusion of IV insulin."
